{"query_1": {"query": "Give me an overview of the Reliance stock", "response": "Here\u2019s a comprehensive overview of Reliance Industries Limited (RELIANCE) as of 7 August 2025, reflecting the latest financials, market context, and recent developments:\n\n### Key Financials & Valuation\n\n| Metric | Value |\n|-----------------------|-----------------------------|\n| **Current Price** | **\u20b91,387** |\n| **Market Cap** | **\u20b918.9 lakh crore** |\n| **PE Ratio** | **13.48** |\n| **PB Ratio** | **1.18** |\n| **PEG Ratio** | **3.08** |\n| **EPS (2024)** | **\u20b9102.9** |\n| **Dividend Yield** | **0.34%** |\n| **Promoter Holding** | **50.07%** |\n| **FII Holding** | **19.21%** |\n| **DII Holding** | **19.89%** |\n\n### Financial Performance (\u20b9 crore)\n\n| Year | Total Revenue | Net Profit | Profit Margin | ROE (%) | ROCE (%) |\n|------|--------------|------------|---------------|---------|----------|\n| 2022 | 71,09,060 | 60,705 | 8.39% | 9.2 | 9.68 |\n| 2023 | 89,08,710 | 66,702 | 7.56% | 9.86 | 10.95 |\n| 2024 | 91,71,210 | 69,621 | 7.9% | 10.48 | 11.9 |\n\n- **Steady revenue and profit growth** with improving return ratios, indicating operational efficiency.\n\n### Mutual Fund Holdings (Top 5 as of June 2025)\n\n| AMC | Scheme Name | Holding (%) |\n|----------------------------------------|------------------------------------|-------------|\n| UTI AMC | UTI Nifty 50 ETF | 8.76 |\n| UTI AMC | UTI BSE Sensex ETF | 10.30 |\n| UTI AMC | UTI Nifty 50 Index Fund | 8.77 |\n| Quant Money Managers | Quant ELSS Tax Saver Fund | 9.84 |\n| Quant Money Managers | Quant Multi Cap Fund | 9.85 |\n\n- **Strong institutional interest** signals confidence in RIL\u2019s long-term prospects.\n\n### Recent News & Developments\n\n- **Leadership transition**: Mukesh Ambani is preparing his children for succession, with a focus on green energy and AI.\n- **Green energy push**: RIL is investing \u20b983,000 crore ($10 billion) in renewables, aiming for net-zero by 2035, but progress is gradual.\n- **Market volatility**: Stock hit a 15-month low of \u20b91,161.40 in March 2025, underperforming the Sensex in the last 6 months.\n- **Analyst ratings**: JP Morgan rates RIL \u201cOverweight\u201d with a target of \u20b93,100; Goldman Sachs maintains \u201cBuy\u201d with a target of \u20b91,595.\n- **Sectoral context**: RIL is India\u2019s largest crude oil and petrochemical player, now diversifying into data centers and green hydrogen.\n\n### Market Sentiment & Outlook\n\n- **Analysts remain optimistic** about RIL\u2019s new energy and AI ventures, though near-term risks include global trade tensions and execution delays.\n- **Ownership structure** is stable, with high promoter and institutional holdings.\n\nWould you like a deeper dive into Reliance\u2019s green energy strategy, technical analysis, or details on its upcoming IPOs?\n\n<>{\"type\": \"follow-up\", \"options\": [{\"label\": \"label_0\", \"value\": \"How has the Reliance stock price performed relative to its sector peers?\"}, {\"label\": \"label_1\", \"value\": \"How is the overall crude oil sector performing?\"}, {\"label\": \"label_2\", \"value\": \"What are the key financial ratios for Reliance, such as P/E, P/B, and dividend yield?\"}, {\"label\": \"label_3\", \"value\": \"Are there any recent negative news around Reliance?\"}]}<>", "follow_up_ids": ["query_1.01", "query_1.02", "query_1.03", "query_1.04"], "follow_up": ["How has the Reliance stock price performed relative to its sector peers?", "How is the overall crude oil sector performing?", "What are the key financial ratios for Reliance, such as P/E, P/B, and dividend yield?", "Are there any recent negative news around Reliance?"]}, "query_1.01": {"query": "How has the Reliance stock price performed relative to its sector peers?", "response": "<>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `How has the Reliance Industries (RELIANCE) stock price performed relative to its sector peers in the Crude Oil sector?`\"}<><>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `How has the Reliance stock price performed relative to its sector peers?`\"}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"ADANIENT reports a 16.31% fall in net profit for Q1FY26, down to Rs 504.04 crore.\"}, {\"heading\": \"Market News Update\", \"content\": \"GESHIP reports 41.87% fall in Q1 net profit to Rs 388.45 crore for FY26.\"}, {\"heading\": \"Market News Update\", \"content\": \"COALINDIA reports 32.60% rise in Q1FY26 net profit, despite an 8.53% drop in total income.\"}]}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"PNBHOUSING reaffirms growth and stability amid leadership changes, per recent press release.\"}, {\"heading\": \"Market News Update\", \"content\": \"NTPCGREEN submitted a Monitoring Agency Report on IPO fund utilization for the June 2025 quarter.\"}, {\"heading\": \"Market News Update\", \"content\": \"Suzlon Energy announces a 381 MW order for Power Zelestra's first FDRE project.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the stock overview for the stock : Reliance Industries\"}<><>{\"type\": \"text\", \"values\": \"Stock: RELIANCE1\\n\"}<><>{\"type\": \"text\", \"values\": \"Last Traded: \\u20b91391.70 | Sector: Crude Oil | Industry: Refineries | Market Cap: \\u20b91,890,000 Cr

\"}<><>{\"type\": \"text\", \"values\": \"Reliance Industries is a diversified conglomerate with strong presence across energy, retail, and digital services sectors, representing a robust multi-dimensional business model. The company demonstrates consistent financial strength, with a market capitalization of \\u20b918,900 crores, promoter holding at 50.07%, and a steady revenue growth trajectory from \\u20b94,840 crores in 2021 to \\u20b99,171 crores in 2024.\"}<>\n<>{\"type\": \"stock_chart\", \"values\": \"RELIANCE\"}<><>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Analyst recommendation and Stock score for RELIANCE 2\"}, \"answer\": [{\"type\": \"analyst_ranking\", \"values\": [{\"title\": \"Strong Buy\", \"pct\": 37.5, \"color\": \"#19A574\"}, {\"title\": \"Buy\", \"pct\": 53.12, \"color\": \"#4EE2AE\"}, {\"title\": \"Hold\", \"pct\": 3.12, \"color\": \"#D3D3D3\"}, {\"title\": \"Sell\", \"pct\": 6.25, \"color\": \"#EA6776\"}, {\"title\": \"Strong Sell\", \"pct\": 0, \"color\": \"#D8011B\"}]}, {\"type\": \"stock_score_report\", \"values\": {\"heading\": {\"title\": \"Stock Score\", \"image_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\"}, \"score_info\": {\"score\": 9, \"score_max\": 10, \"image_url\": \"https://storage.googleapis.com/insights_page_assets/scores/fire.png\", \"bg_color\": \"#CBFFB7\", \"fill_color\": \"#58DE6B\"}, \"outlook\": {\"text\": \"Positive Outlook\", \"color\": \"#359501\"}, \"indicator_bg_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\", \"indicators\": [{\"name\": \"Earnings\", \"score\": 8}, {\"name\": \"Fundamentals\", \"score\": 8}, {\"name\": \"Relative Valuation\", \"score\": 7}, {\"name\": \"Risk\", \"score\": 10}, {\"name\": \"Price Momentum\", \"score\": 6}], \"legend\": [{\"title\": \"NEGATIVE (1-4)\", \"color\": \"#FF8080\"}, {\"title\": \"NEUTRAL (5-7)\", \"color\": \"#F8F4A6\"}, {\"title\": \"POSITIVE (8-10)\", \"color\": \"#B3FFBE\"}], \"show_empty_ui\": false}}], \"initialOpen\": true}}<><>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"SEBI Experts' recommendation\"}, \"answer\": [{\"type\": \"trade_views\", \"values\": [{\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -19.8, \"percentage\": -1.4, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 11.68, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1413, \"target_price\": 1554.3, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 13.1, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}, {\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -19.8, \"percentage\": -1.4, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 5.7, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1401, \"target_price\": 1471.05, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 11.72, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}, {\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -19.8, \"percentage\": -1.4, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 10.66, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1400, \"target_price\": 1540, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 5.6, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}]}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Growth metrics 3\"}, \"answer\": [{\"type\": \"text\", \"values\": \"Revenue growth (YoY): 2.95%\\nNet profit growth (YoY): 4.38%\\nProfit margin growth (YoY): 4.50%\\nPE ratio: 13.52 compared to sector: 49.36 : Undervalued\\nShort-term POV : EMA (200) : \\u20b91542.88 : Bearish\\nLong-term POV : SMA (200) : \\u20b91326.09 : Bullish\\nNext Support: \\u20b91396.77 | Next Resistance: \\u20b91421.17\"}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Returns comparison\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Timeframe\": [\"Daily\", \"Weekly\", \"Monthly\", \"6 Months\", \"Yearly\"], \"Stock Return\": [\"-1.40%\", \"-1.79%\", \"-9.72%\", \"10.01%\", \"-7.55%\"], \"Industry Return\": [\"-1.02%\", \"-5.08%\", \"-10.73%\", \"11.50%\", \"-19.25%\"], \"Analysis\": [\"Underperformed wrt industry by 0.38%\", \"Outperformed wrt industry by 3.29%\", \"Outperformed wrt industry by 1.01%\", \"Underperformed wrt industry by 1.49%\", \"Outperformed wrt industry by 11.70%\"]}}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Shareholding pattern\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Category\": [\"FII\", \"DII\", \"PROMOTERS\", \"PUBLIC\", \"OTHERS\"], \"DEC'24\": [19.16, 19.15, 50.13, 11.55, 0.01], \"MAR'25\": [19.07, 19.51, 50.11, 11.31, 0], \"JUN'25\": [19.21, 19.89, 50.07, 10.83, 0], \"Trend\": [\"Recently increased (+0.14%)\", \"Consistently increasing (+0.38%)\", \"Consistently decreasing (-0.04%)\", \"Consistently decreasing (-0.48%)\", \"No change\"]}}]}}<><>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `How has the Reliance stock price performed relative to its sector peers?`\"}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the sector overview for the sector : Crude Oil\"}<><>{\"type\": \"text\", \"values\": \"Sector Overview: Crude Oil\\nMarket Cap: 27.25 lakh Cr | Market Cap Share: 6.68% | Sector ROE: 15.05%

The Oil & Gas sector presents a diverse investment landscape with a balanced market cap distribution (40% Large, 20% Mid, 40% Small Cap), featuring key players like Reliance and ONGC, which have demonstrated resilience despite recent short-term volatility and underperformance against Nifty in most timeframes.\"}<><>{\"type\": \"table\", \"values\": {\"Market Cap\": [\"Large Cap\", \"Mid Cap\", \"Small Cap\"], \"Percentage\": [\"40.0 %\", \"20.0 %\", \"40.0 %\"], \"Companies\": [4, 2, 4]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Top companies by Market Cap\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Stock\": [\"RELIANCE\", \"ONGC\", \"IOC\", \"BPCL\", \"HINDPETRO\"], \"Market Cap (Cr)\": [\"1890000.0\", \"300000.0\", \"200000.0\", \"140000.0\", \"85920.0\"], \"Weekly Return\": [\"-0.54%\", \"-3.33%\", \"-3.24%\", \"-5.92%\", \"-4.42%\"], \"Revenue (Cr)\": [\"917121.0\", \"0.0\", \"780194.75\", \"450318.31\", \"435773.44\"], \"PE\": [\"13.48\", \"5.97\", \"4.67\", \"9.95\", \"12.7\"], \"Score\": [\"9\", \"7\", \"7\", \"9\", \"8\"], \"ROE (%)\": [\"10.48\", \"18.42\", \"26.71\", \"41.59\", \"40.45\"]}}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Returns comparison\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Timeframe\": [\"Daily\", \"Weekly\", \"Monthly\", \"6 Months\", \"Yearly\"], \"Sector Return\": [\"-0.94%\", \"-3.95%\", \"-11.13%\", \"16.43%\", \"-19.44%\"], \"Nifty Return\": [\"0.09%\", \"-0.70%\", \"-3.40%\", \"4.40%\", \"1.23%\"], \"Analysis\": [\"Underperformed wrt nifty by 1.03%\", \"Underperformed wrt nifty by 3.25%\", \"Underperformed wrt nifty by 7.73%\", \"Outperformed wrt nifty by 12.03%\", \"Underperformed wrt nifty by 20.67%\"]}}]}}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"WAAREEENER is up 1.48% at Rs. 3037.00 with 52-week highs of Rs. 3740.75.\"}, {\"heading\": \"Market News Update\", \"content\": \"Suzlon Energy announces a 381 MW order for Power Zelestra's first FDRE project.\"}, {\"heading\": \"Market News Update\", \"content\": \"NEOGEN is trading at Rs. 1550.50, rising 0.53% amid new subsidiary announcement.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Gathering comprehensive stock performance details for Reliance Industries to establish baseline metrics.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Identifying and collecting performance data across all stocks within the crude oil sector to create a comparative framework.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Conducting a multi-dimensional performance comparison by evaluating Reliance's returns across various time intervals against sector benchmarks and individual competitor performances.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Executing an in-depth relative performance assessment by examining price dynamics, market capitalization positioning, and comparative valuation metrics within the sector landscape.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Exploring Reliance's sector classification and tracking its key performance indicators.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Scanning the market landscape to pinpoint significant stocks operating within Reliance's industry segment.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Systematically evaluating Reliance's financial metrics against comparable sector companies through comprehensive comparative analysis.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Conducting a multi-temporal performance assessment across different time horizons to understand Reliance's market positioning.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Synthesizing strategic insights that illuminate Reliance's competitive standing relative to established sector benchmarks.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the stock overview for the stock : Reliance Industries\"}<><>{\"type\": \"text\", \"values\": \"Stock: RELIANCE1\\n\"}<><>{\"type\": \"text\", \"values\": \"Last Traded: \\u20b91391.70 | Sector: Crude Oil | Industry: Refineries | Market Cap: \\u20b91,890,000 Cr

\"}<><>{\"type\": \"text\", \"values\": \"Reliance Industries is a diversified conglomerate with strong presence across energy, retail, and digital services sectors, representing a robust multi-dimensional business model. The company demonstrates consistent financial strength, with a market capitalization of \\u20b918,900 crores, promoter holding at 50.07%, and a steady revenue growth trajectory from \\u20b94,840 crores in 2021 to \\u20b99,171 crores in 2024.\"}<>\n<>{\"type\": \"stock_chart\", \"values\": \"RELIANCE\"}<><>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Analyst recommendation and Stock score for RELIANCE 2\"}, \"answer\": [{\"type\": \"analyst_ranking\", \"values\": [{\"title\": \"Strong Buy\", \"pct\": 37.5, \"color\": \"#19A574\"}, {\"title\": \"Buy\", \"pct\": 53.12, \"color\": \"#4EE2AE\"}, {\"title\": \"Hold\", \"pct\": 3.12, \"color\": \"#D3D3D3\"}, {\"title\": \"Sell\", \"pct\": 6.25, \"color\": \"#EA6776\"}, {\"title\": \"Strong Sell\", \"pct\": 0, \"color\": \"#D8011B\"}]}, {\"type\": \"stock_score_report\", \"values\": {\"heading\": {\"title\": \"Stock Score\", \"image_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\"}, \"score_info\": {\"score\": 9, \"score_max\": 10, \"image_url\": \"https://storage.googleapis.com/insights_page_assets/scores/fire.png\", \"bg_color\": \"#CBFFB7\", \"fill_color\": \"#58DE6B\"}, \"outlook\": {\"text\": \"Positive Outlook\", \"color\": \"#359501\"}, \"indicator_bg_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\", \"indicators\": [{\"name\": \"Earnings\", \"score\": 8}, {\"name\": \"Fundamentals\", \"score\": 8}, {\"name\": \"Relative Valuation\", \"score\": 7}, {\"name\": \"Risk\", \"score\": 10}, {\"name\": \"Price Momentum\", \"score\": 6}], \"legend\": [{\"title\": \"NEGATIVE (1-4)\", \"color\": \"#FF8080\"}, {\"title\": \"NEUTRAL (5-7)\", \"color\": \"#F8F4A6\"}, {\"title\": \"POSITIVE (8-10)\", \"color\": \"#B3FFBE\"}], \"show_empty_ui\": false}}], \"initialOpen\": true}}<><>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"SEBI Experts' recommendation\"}, \"answer\": [{\"type\": \"trade_views\", \"values\": [{\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -19.8, \"percentage\": -1.4, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 11.68, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1413, \"target_price\": 1554.3, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 13.1, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}, {\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -19.8, \"percentage\": -1.4, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 5.7, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1401, \"target_price\": 1471.05, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 11.72, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}, {\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -19.8, \"percentage\": -1.4, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 10.66, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1400, \"target_price\": 1540, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 5.6, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}]}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Growth metrics 3\"}, \"answer\": [{\"type\": \"text\", \"values\": \"Revenue growth (YoY): 2.95%\\nNet profit growth (YoY): 4.38%\\nProfit margin growth (YoY): 4.50%\\nPE ratio: 13.52 compared to sector: 49.36 : Undervalued\\nShort-term POV : EMA (200) : \\u20b91542.88 : Bearish\\nLong-term POV : SMA (200) : \\u20b91326.09 : Bullish\\nNext Support: \\u20b91396.77 | Next Resistance: \\u20b91421.17\"}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Returns comparison\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Timeframe\": [\"Daily\", \"Weekly\", \"Monthly\", \"6 Months\", \"Yearly\"], \"Stock Return\": [\"-1.40%\", \"-1.79%\", \"-9.72%\", \"10.01%\", \"-7.55%\"], \"Industry Return\": [\"-1.02%\", \"-5.08%\", \"-10.73%\", \"11.50%\", \"-19.25%\"], \"Analysis\": [\"Underperformed wrt industry by 0.38%\", \"Outperformed wrt industry by 3.29%\", \"Outperformed wrt industry by 1.01%\", \"Underperformed wrt industry by 1.49%\", \"Outperformed wrt industry by 11.70%\"]}}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Shareholding pattern\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Category\": [\"FII\", \"DII\", \"PROMOTERS\", \"PUBLIC\", \"OTHERS\"], \"DEC'24\": [19.16, 19.15, 50.13, 11.55, 0.01], \"MAR'25\": [19.07, 19.51, 50.11, 11.31, 0], \"JUN'25\": [19.21, 19.89, 50.07, 10.83, 0], \"Trend\": [\"Recently increased (+0.14%)\", \"Consistently increasing (+0.38%)\", \"Consistently decreasing (-0.04%)\", \"Consistently decreasing (-0.48%)\", \"No change\"]}}]}}<><>{\"type\": \"thinking_step\", \"values\": \"Analyzing Reliance stock's performance by comparing it with sector peers, focusing on understanding its market positioning and comparative metrics.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Gathering comprehensive stock details for Reliance, including its sector classification and performance returns.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Identifying and collecting information about companies operating in the same sector as Reliance.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Extracting performance metrics for sector peer stocks to enable a robust comparative analysis.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Conducting a multi-dimensional performance evaluation across various time horizons, ranging from daily to yearly intervals.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Benchmarking Reliance's key valuation metrics against sector averages and direct peer comparisons.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Generating comprehensive insights into Reliance's relative market performance and competitive positioning.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Curating the research into a final output to answer the user query\"}<><>{\"type\": \"thinking_step\", \"values\": \"Curating the research into a final output to answer the user query\"}<><>{\"type\": \"thinking_step\", \"values\": \"Curating the research into a final output to answer the user query\"}<><>{\"type\": \"thinking_step\", \"values\": \"Adding SEBI expert recommendations from StockGro for: `RELIANCE`\"}<><>{\"type\": \"thinking_step\", \"values\": \"Adding analyst ratings and stock score from StockGro for: `RELIANCE`\"}<>Reliance Industries operates in the crude oil sector and is classified as a large cap stock. Here\u2019s a detailed comparison of Reliance\u2019s recent performance and valuation against its sector peers and the industry benchmark:\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Stock	Yearly Return (%)	Market Cap (\u20b9 Cr)	PE Ratio	PB Ratio
Reliance	-7.78	Data not available	13.48	1.18
Hindustan Petroleum	2.75	85,920	12.70	1.67
Rain Industries	-3.35	5,140	-9.78	0.83
Bharat Petroleum	-10.75	1,40,000	9.95	1.63
Indian Oil	-20.53	2,00,000	4.67	1.06
Oil India	-28.84	70,600	5.36	1.22

\n\nKey insights:\n- Reliance\u2019s yearly return (**-7.78%**) is better than the sector average (**-19.44%**) and outperforms most peers except Hindustan Petroleum (**2.75%**).\n- On valuation, Reliance\u2019s PE (**13.48**) is higher than most sector peers, indicating a premium, while its PB (**1.18**) is moderate.\n- The sector as a whole has seen negative returns over the past year, with only Hindustan Petroleum showing positive growth.\n- Industry benchmark returns are negative across all timeframes, highlighting sector-wide challenges.\n\nWould you like a deeper dive into recent news, management updates, or analyst ratings for Reliance or any of its peers?<>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"SEBI Experts' recommendation\"}, \"answer\": [{\"type\": \"trade_views\", \"values\": [{\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -3.4, \"percentage\": -0.24, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 11.87, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1413, \"target_price\": 1554.3, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 14.31, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}, {\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -3.4, \"percentage\": -0.24, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 5.88, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1401, \"target_price\": 1471.05, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 14.21, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}, {\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -3.4, \"percentage\": -0.24, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 10.84, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1400, \"target_price\": 1540, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 7.04, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}]}]}}<><>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Analyst recommendation and Stock score for RELIANCE 1\"}, \"answer\": [{\"type\": \"analyst_ranking\", \"values\": [{\"title\": \"Strong Buy\", \"pct\": 37.5, \"color\": \"#19A574\"}, {\"title\": \"Buy\", \"pct\": 53.12, \"color\": \"#4EE2AE\"}, {\"title\": \"Hold\", \"pct\": 3.12, \"color\": \"#D3D3D3\"}, {\"title\": \"Sell\", \"pct\": 6.25, \"color\": \"#EA6776\"}, {\"title\": \"Strong Sell\", \"pct\": 0, \"color\": \"#D8011B\"}]}, {\"type\": \"stock_score_report\", \"values\": {\"heading\": {\"title\": \"Stock Score\", \"image_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\"}, \"score_info\": {\"score\": 9, \"score_max\": 10, \"image_url\": \"https://storage.googleapis.com/insights_page_assets/scores/fire.png\", \"bg_color\": \"#CBFFB7\", \"fill_color\": \"#58DE6B\"}, \"outlook\": {\"text\": \"Positive Outlook\", \"color\": \"#359501\"}, \"indicator_bg_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\", \"indicators\": [{\"name\": \"Earnings\", \"score\": 8}, {\"name\": \"Fundamentals\", \"score\": 8}, {\"name\": \"Relative Valuation\", \"score\": 7}, {\"name\": \"Risk\", \"score\": 10}, {\"name\": \"Price Momentum\", \"score\": 6}], \"legend\": [{\"title\": \"NEGATIVE (1-4)\", \"color\": \"#FF8080\"}, {\"title\": \"NEUTRAL (5-7)\", \"color\": \"#F8F4A6\"}, {\"title\": \"POSITIVE (8-10)\", \"color\": \"#B3FFBE\"}], \"show_empty_ui\": false}}]}}<><>{\"type\": \"follow-up\", \"options\": [{\"label\": \"label_0\", \"value\": \"Are there any recent news or events impacting Reliance Industries or its peers in the crude oil sector?\"}, {\"label\": \"label_1\", \"value\": \"How have the crude oil prices influenced the stock performance of Reliance and its sector competitors recently?\"}, {\"label\": \"label_2\", \"value\": \"Which other Indian companies are major players in the crude oil and petrochemicals sector, and how are they performing?\"}, {\"label\": \"label_3\", \"value\": \"Would you like an analysis of Reliance's recent financial results compared to its sector peers?\"}]}<>", "follow_up": ["Are there any recent news or events impacting Reliance Industries or its peers in the crude oil sector?", "How have the crude oil prices influenced the stock performance of Reliance and its sector competitors recently?", "Which other Indian companies are major players in the crude oil and petrochemicals sector, and how are they performing?", "Would you like an analysis of Reliance's recent financial results compared to its sector peers?"]}, "query_1.02": {"query": "How is the overall crude oil sector performing?", "response": "<>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `How is the overall crude oil sector performing?`\"}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"M&M reports a 25.96% rise in overall auto sales for July 2025 compared to last year.\"}, {\"heading\": \"Market News Update\", \"content\": \"CASTROLIND launches advanced engine oils meeting new API SQ standards, enhancing vehicle lubrication in India.\"}, {\"heading\": \"Market News Update\", \"content\": \"ESCORTS sold 7,154 tractors in July 2025, marking a 2.7% year-on-year growth.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `How is the overall crude oil sector performing?`\"}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the sector overview for the sector : Crude Oil\"}<><>{\"type\": \"text\", \"values\": \"Sector Overview: Crude Oil\\nMarket Cap: 27.25 lakh Cr | Market Cap Share: 6.68% | Sector ROE: 15.05%

The Oil & Gas sector presents a diverse investment landscape with a balanced market cap distribution (40% Large, 20% Mid, 40% Small Cap), featuring key players like Reliance and ONGC, which have demonstrated resilience despite recent short-term volatility, with the sector showing strong 6-month performance of 16.43% outperforming the Nifty.\"}<><>{\"type\": \"table\", \"values\": {\"Market Cap\": [\"Large Cap\", \"Mid Cap\", \"Small Cap\"], \"Percentage\": [\"40.0 %\", \"20.0 %\", \"40.0 %\"], \"Companies\": [4, 2, 4]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Top companies by Market Cap\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Stock\": [\"RELIANCE\", \"ONGC\", \"IOC\", \"BPCL\", \"HINDPETRO\"], \"Market Cap (Cr)\": [\"1890000.0\", \"300000.0\", \"200000.0\", \"140000.0\", \"85920.0\"], \"Weekly Return\": [\"-0.54%\", \"-3.33%\", \"-3.24%\", \"-5.92%\", \"-4.42%\"], \"Revenue (Cr)\": [\"917121.0\", \"0.0\", \"780194.75\", \"450318.31\", \"435773.44\"], \"PE\": [\"13.48\", \"5.97\", \"4.67\", \"9.95\", \"12.7\"], \"Score\": [\"9\", \"7\", \"7\", \"9\", \"8\"], \"ROE (%)\": [\"10.48\", \"18.42\", \"26.71\", \"41.59\", \"40.45\"]}}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Returns comparison\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Timeframe\": [\"Daily\", \"Weekly\", \"Monthly\", \"6 Months\", \"Yearly\"], \"Sector Return\": [\"-0.94%\", \"-3.95%\", \"-11.13%\", \"16.43%\", \"-19.44%\"], \"Nifty Return\": [\"0.09%\", \"-0.70%\", \"-3.40%\", \"4.40%\", \"1.23%\"], \"Analysis\": [\"Underperformed wrt nifty by 1.03%\", \"Underperformed wrt nifty by 3.25%\", \"Underperformed wrt nifty by 7.73%\", \"Outperformed wrt nifty by 12.03%\", \"Underperformed wrt nifty by 20.67%\"]}}]}}<><>{\"type\": \"thinking_step\", \"values\": \"Exploring the comprehensive landscape of crude oil sector stocks and their current market positioning.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Conducting a systematic evaluation of sector performance metrics across multiple time horizons.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Pinpointing the standout performers and underperforming entities within the crude oil sector.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Collecting and synthesizing recent developments and news impacting the crude oil sector.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Constructing a holistic sector overview highlighting key performance insights and strategic observations.\"}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"TVSMOTOR reports 456,350 monthly sales in July 2025, up 29% year-over-year.\"}, {\"heading\": \"Market News Update\", \"content\": \"SUNDRMFAST hosted a conference call, sharing no unpublished price sensitive information with analysts.\"}, {\"heading\": \"Market News Update\", \"content\": \"Suzlon won a 381 MW order from Zelestra India, furthering its renewable energy collaboration.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the sector overview for the sector : Crude Oil\"}<><>{\"type\": \"text\", \"values\": \"Sector Overview: Crude Oil\\nMarket Cap: 27.25 lakh Cr | Market Cap Share: 6.68% | Sector ROE: 15.05%

The Oil & Gas sector presents a diverse investment landscape with a balanced market cap distribution (40% Large, 20% Mid, 40% Small Cap), featuring key players like Reliance and ONGC, which have demonstrated resilience despite recent short-term volatility and underperformance against Nifty in most timeframes.\"}<><>{\"type\": \"table\", \"values\": {\"Market Cap\": [\"Large Cap\", \"Mid Cap\", \"Small Cap\"], \"Percentage\": [\"40.0 %\", \"20.0 %\", \"40.0 %\"], \"Companies\": [4, 2, 4]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Top companies by Market Cap\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Stock\": [\"RELIANCE\", \"ONGC\", \"IOC\", \"BPCL\", \"HINDPETRO\"], \"Market Cap (Cr)\": [\"1890000.0\", \"300000.0\", \"200000.0\", \"140000.0\", \"85920.0\"], \"Weekly Return\": [\"-0.54%\", \"-3.33%\", \"-3.24%\", \"-5.92%\", \"-4.42%\"], \"Revenue (Cr)\": [\"917121.0\", \"0.0\", \"780194.75\", \"450318.31\", \"435773.44\"], \"PE\": [\"13.48\", \"5.97\", \"4.67\", \"9.95\", \"12.7\"], \"Score\": [\"9\", \"7\", \"7\", \"9\", \"8\"], \"ROE (%)\": [\"10.48\", \"18.42\", \"26.71\", \"41.59\", \"40.45\"]}}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Returns comparison\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Timeframe\": [\"Daily\", \"Weekly\", \"Monthly\", \"6 Months\", \"Yearly\"], \"Sector Return\": [\"-0.94%\", \"-3.95%\", \"-11.13%\", \"16.43%\", \"-19.44%\"], \"Nifty Return\": [\"0.09%\", \"-0.70%\", \"-3.40%\", \"4.40%\", \"1.23%\"], \"Analysis\": [\"Underperformed wrt nifty by 1.03%\", \"Underperformed wrt nifty by 3.25%\", \"Underperformed wrt nifty by 7.73%\", \"Outperformed wrt nifty by 12.03%\", \"Underperformed wrt nifty by 20.67%\"]}}]}}<><>{\"type\": \"thinking_step\", \"values\": \"Identifying and collecting all stocks associated with the crude oil sector.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Conducting a comprehensive performance evaluation across various time intervals.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Pinpointing the most successful and least performing stocks within the crude oil sector.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Collecting and reviewing recent news coverage related to the crude oil sector to understand market dynamics and influencing factors.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Synthesizing a comprehensive sector overview highlighting performance insights, critical metrics, and emerging market trends.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Curating the research into a final output to answer the user query\"}<>The Indian crude oil sector, as of August 7, 2025, is experiencing notable volatility due to global geopolitical shifts and evolving domestic strategies. Here\u2019s a comprehensive snapshot of the sector\u2019s current performance and outlook:\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Company	Price (\u20b9)	Market Cap (\u20b9 crore)	Daily Return (%)	Yearly Return (%)	PE Ratio	Volume
Reliance Industries	1,387.00	18,90,000	-0.73	-7.78	13.48	76,32,759
ONGC	233.48	3,00,000	-0.34	-29.42	5.97	43,75,549
IOC	141.55	2,00,000	-0.96	-20.53	4.67	59,22,809
BPCL	310.40	1,40,000	-1.88	-10.75	9.95	36,35,605
Hindustan Petroleum	401.95	85,920	-0.36	2.75	12.70	50,66,702

\n\n**Sector Highlights:**\n- The sector\u2019s average PE ratio is 48.20, indicating high valuation relative to earnings.\n- Most major stocks have posted negative returns over the past year, with ONGC and IOC seeing the steepest declines.\n- Volumes remain robust, reflecting active trading despite price corrections.\n\n**Recent Developments:**\n- The announcement of a 25% U.S. tariff on Indian imports due to Russian oil purchases is expected to impact demand-supply dynamics (details).\n- Indian refiners are diversifying crude sources, reducing reliance on Russia and increasing imports from the Middle East and other regions (read more).\n- Infrastructure upgrades, such as the near-completion of the JHBDPL pipeline, are strengthening supply chains.\n- Policy reforms, including the Oilfields Amendment Bill, are set to attract private investment and modernize the sector.\n\n**Market Sentiment & Outlook:**\n- Short-term sentiment is cautious due to margin pressures on oil marketing companies and global trade tensions.\n- Analysts project sector growth in FY26 and FY27, with Reliance, GAIL, and MGL among top picks.\n\nWould you like a deeper dive into any specific company\u2019s financials or want to explore how these sector trends could impact your investment strategy?<>{\"type\": \"follow-up\", \"options\": [{\"label\": \"label_0\", \"value\": \"Are there any recent news or policy changes impacting the crude oil sector in India?\"}, {\"label\": \"label_1\", \"value\": \"How are major companies like Reliance Industries and ONGC performing within the crude oil sector?\"}, {\"label\": \"label_2\", \"value\": \"What are the recent trends in crude oil prices and how might they influence Indian oil stocks?\"}, {\"label\": \"label_3\", \"value\": \"Are there any upcoming events or reports that could significantly impact the crude oil industry in India?\"}]}<>", "follow_up": ["Are there any recent news or policy changes impacting the crude oil sector in India?", "How are major companies like Reliance Industries and ONGC performing within the crude oil sector?", "What are the recent trends in crude oil prices and how might they influence Indian oil stocks?", "Are there any upcoming events or reports that could significantly impact the crude oil industry in India?"]}, "query_1.03": {"query": "What are the key financial ratios for Reliance, such as P/E, P/B, and dividend yield?", "response": "Here\u2019s a focused snapshot of Reliance Industries\u2019 key financial ratios and market data as of 7th August 2025, with context relevant to the Indian market:\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Metric	Reliance	Sector Average
P/E Ratio	13.48	48.20
P/B Ratio	1.18	1.31
Dividend Yield	0.34%	\u2014
Last Trade Price	\u20b91,387.00	\u2014
Market Cap	\u20b918.9 lakh crore	\u2014

\n\n- Reliance\u2019s P/E ratio of 13.48 is significantly lower than the sector average, suggesting the stock may be undervalued relative to its peers.\n- The P/B ratio of 1.18 is also below the sector\u2019s 1.31, indicating a conservative valuation on book value.\n- Dividend yield stands at 0.34%, reflecting Reliance\u2019s focus on reinvestment and growth rather than high dividend payouts.\n- The market cap of \u20b918.9 lakh crore highlights Reliance\u2019s position as one of India\u2019s largest companies.\n\nWould you like a deeper breakdown of how these ratios impact investment decisions, or insights into recent trends for Reliance?<>{\"type\": \"follow-up\", \"options\": [{\"label\": \"label_0\", \"value\": \"How has Reliance Industries' stock price reacted to recent crude oil price fluctuations?\"}, {\"label\": \"label_1\", \"value\": \"Are there any recent news or developments impacting Reliance's crude oil segment?\"}, {\"label\": \"label_2\", \"value\": \"What are the latest analyst opinions or target prices for Reliance in the current market?\"}, {\"label\": \"label_3\", \"value\": \"How does Reliance's valuation compare with other major Indian oil and gas companies?\"}]}<>", "follow_up": ["How has Reliance Industries' stock price reacted to recent crude oil price fluctuations?", "Are there any recent news or developments impacting Reliance's crude oil segment?", "What are the latest analyst opinions or target prices for Reliance in the current market?", "How does Reliance's valuation compare with other major Indian oil and gas companies?"]}, "query_1.04": {"query": "Are there any recent negative news around Reliance?", "response": "<>{\"type\": \"thinking_step\", \"values\": \"Searching through recent news reports focusing specifically on Reliance Industries.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Identifying and extracting news articles with negative sentiment or adverse reporting about the company.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Conducting an in-depth analysis of the negative news content and evaluating its potential impact on stock performance.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Compiling and presenting comprehensive findings about the negative news reports with relevant contextual details.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Adding SEBI expert recommendations from StockGro for: `RELIANCE`\"}<><>{\"type\": \"thinking_step\", \"values\": \"Adding analyst ratings and stock score from StockGro for: `RELIANCE`\"}<>Reliance Industries Limited (RIL) has recently faced several negative developments impacting its stock performance in the Indian markets as of August 7, 2025. Here\u2019s a concise summary of the key adverse news and their significance:\n\n| Negative Event | Impact on RIL Stock/Business | Key Figures/Details |\n|-----------------------------------------------------|---------------------------------------------------------------------------------------------|------------------------------------------------------|\n| Geopolitical & Tariff Concerns | Raised risk of losing access to cheaper Russian crude, squeezing refining margins | Stock fell **1%** after US imposed 25% duty on India |\n| Delay in Reliance Jio IPO | Postponement led to negative sentiment and market drag | Stock dropped **1.8%** |\n| Disappointing Q1 Results | Underperformance in oil-to-chemicals and retail segments | Shares down **2%**; profit up **78%** (one-off gain) |\n| Regulatory Penalty Risk (RNEL) | Potential penalty for missing PLI scheme deadline on battery plant | Up to **\u20b9125 crore** penalty |\n| Market Cap Decline | Subdued retail and O2C earnings led to sharp fall in valuation | Market cap down over **\u20b95 lakh crore** |\n\n**Significance and Trends:**\n- The combination of global trade uncertainties, regulatory hurdles, and operational underperformance has led to a sharp decline in RIL\u2019s market capitalization and negative market sentiment.\n- The delay in Reliance Jio\u2019s IPO and missed targets in new energy initiatives have raised concerns about execution risks in RIL\u2019s diversification strategy.\n- Analysts have downgraded their outlook on RIL\u2019s retail and O2C segments, reflecting caution in the near term.\n\n**Recent Negative News Links:**\n- Tariff jitters may hit demand-supply balance\n- Reliance Jio delays IPO\n- Key segments' results disappoint\n\nWould you like a deeper analysis of how these factors could affect RIL\u2019s future stock performance or need help understanding any of these developments in detail?<>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"SEBI Experts' recommendation\"}, \"answer\": [{\"type\": \"trade_views\", \"values\": [{\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -3.4, \"percentage\": -0.24, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 11.87, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1413, \"target_price\": 1554.3, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 14.31, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}, {\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -3.4, \"percentage\": -0.24, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 5.88, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1401, \"target_price\": 1471.05, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 14.21, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}, {\"stock_meta\": {\"identifier\": \"RELIANCE\", \"name\": \"Reliance Industries\", \"image_url\": \"https://storage.googleapis.com/stocks_logo/stocks/RELIANCE.png?q=1\", \"market_price_change\": {\"value\": -3.4, \"percentage\": -0.24, \"type\": \"NEGATIVE\"}}, \"profit_left\": {\"percentage\": 10.84, \"text_prefix\": \"\", \"text_suffix\": \"Profit left \\ud83d\\udc8e\", \"type\": \"POSITIVE\", \"color\": \"GREEN\"}, \"entry_price\": 1400, \"target_price\": 1540, \"direction\": \"Bullish\", \"progress_bar\": {\"entry_position\": 7.04, \"indicator_position\": 0, \"target_position\": 100, \"is_negative_trade\": true}, \"trade_duration\": \"Short Term\"}]}]}}<><>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Analyst recommendation and Stock score for RELIANCE 1\"}, \"answer\": [{\"type\": \"analyst_ranking\", \"values\": [{\"title\": \"Strong Buy\", \"pct\": 37.5, \"color\": \"#19A574\"}, {\"title\": \"Buy\", \"pct\": 53.12, \"color\": \"#4EE2AE\"}, {\"title\": \"Hold\", \"pct\": 3.12, \"color\": \"#D3D3D3\"}, {\"title\": \"Sell\", \"pct\": 6.25, \"color\": \"#EA6776\"}, {\"title\": \"Strong Sell\", \"pct\": 0, \"color\": \"#D8011B\"}]}, {\"type\": \"stock_score_report\", \"values\": {\"heading\": {\"title\": \"Stock Score\", \"image_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\"}, \"score_info\": {\"score\": 9, \"score_max\": 10, \"image_url\": \"https://storage.googleapis.com/insights_page_assets/scores/fire.png\", \"bg_color\": \"#CBFFB7\", \"fill_color\": \"#58DE6B\"}, \"outlook\": {\"text\": \"Positive Outlook\", \"color\": \"#359501\"}, \"indicator_bg_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\", \"indicators\": [{\"name\": \"Earnings\", \"score\": 8}, {\"name\": \"Fundamentals\", \"score\": 8}, {\"name\": \"Relative Valuation\", \"score\": 7}, {\"name\": \"Risk\", \"score\": 10}, {\"name\": \"Price Momentum\", \"score\": 6}], \"legend\": [{\"title\": \"NEGATIVE (1-4)\", \"color\": \"#FF8080\"}, {\"title\": \"NEUTRAL (5-7)\", \"color\": \"#F8F4A6\"}, {\"title\": \"POSITIVE (8-10)\", \"color\": \"#B3FFBE\"}], \"show_empty_ui\": false}}]}}<><>{\"type\": \"follow-up\", \"options\": [{\"label\": \"label_0\", \"value\": \"Have there been any recent changes in Reliance Industries' crude oil production or exploration activities?\"}, {\"label\": \"label_1\", \"value\": \"How has Reliance Industries' stock responded to recent crude oil price fluctuations?\"}, {\"label\": \"label_2\", \"value\": \"Are there any analyst reports or earnings forecasts that reflect the impact of recent crude oil sector developments on Reliance?\"}, {\"label\": \"label_3\", \"value\": \"What is the overall trend in crude oil prices in India lately, and how might that influence Reliance's stock performance?\"}]}<>", "follow_up": ["Have there been any recent changes in Reliance Industries' crude oil production or exploration activities?", "How has Reliance Industries' stock responded to recent crude oil price fluctuations?", "Are there any analyst reports or earnings forecasts that reflect the impact of recent crude oil sector developments on Reliance?", "What is the overall trend in crude oil prices in India lately, and how might that influence Reliance's stock performance?"]}, "query_2": {"query": "How is the healthcare sector performing in the last 5 days?", "response": "<>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"RRKABEL reports 38.93% profit rise, totaling Rs 88.76 crore for Q1FY26.\"}, {\"heading\": \"Market News Update\", \"content\": \"Wonderla Holidays has submitted an investor presentation to BSE.\"}, {\"heading\": \"Market News Update\", \"content\": \"NTPCGREEN submitted a Monitoring Agency Report on IPO fund utilization for the June 2025 quarter.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the sector overview for the sector : Healthcare\"}<><>{\"type\": \"text\", \"values\": \"Sector Overview: Healthcare\\nMarket Cap: 28.46 lakh Cr | Market Cap Share: 6.98% | Sector ROE: 14.75%

Stock	Market Cap (\u20b9 Crore)	Daily Return (%)
SUNPHARMA	3,90,000	-
DIVISLAB	1,70,000	-
MAXHEALTH	1,20,000	-
CIPLA	1,20,000	-
TORNTPHARM	1,20,000	-

\n\n- Lupin posted the highest positive daily return at 4.74%, indicating strong investor sentiment, possibly due to positive news or results.\n- GPT Healthcare saw the largest negative daily return at -8.59%, reflecting sector volatility or company-specific developments.\n\nSector News & Trends:\n- Major state-level health initiatives (e.g., expanded free check-ups, digital health systems) are boosting healthcare demand and infrastructure.\n- The national dialysis program now covers 751 districts, expanding access to critical care.\n- AI adoption in healthcare is accelerating, with the market expected to reach $1.6 billion by 2025 (CAGR: 40.6%).\n- The overall healthcare sector is projected to grow to $638 billion by 2025, with hospitals leading at 80% of sector spending.\n\nSignificance:\n- These policy moves and tech advancements are likely to support long-term growth and investor confidence in healthcare stocks.\n- Recent stock movements reflect both optimism (Lupin) and caution (GPT Healthcare) amid sectoral changes.\n\nWould you like a deeper dive into any specific healthcare stock, or need help understanding how these sector trends could impact your investment strategy?\n\n<>{\"type\": \"follow-up\", \"options\": [{\"label\": \"label_0\", \"value\": \"What are the key trends impacting the performance of the Indian healthcare sector?\"}, {\"label\": \"label_1\", \"value\": \"What opportunities does the Indian healthcare sector see in the global weight-loss drug market?\"}, {\"label\": \"label_2\", \"value\": \"How has these stocks been moving in the last 5 days?\"}, {\"label\": \"label_3\", \"value\": \"What is the growth outlook for the Indian pharmaceutical sector?\"}]}<>", "follow_up_ids": ["query_2.01", "query_2.02", "query_2.03", "query_2.04"], "follow_up": ["What are the key trends impacting the performance of the Indian healthcare sector?", "What opportunities does the Indian healthcare sector see in the global weight-loss drug market?", "How has these stocks been moving in the last 5 days?", "What is the growth outlook for the Indian pharmaceutical sector?"]}, "query_2.01": {"query": "What are the key trends impacting the performance of the Indian healthcare sector?", "response": "<>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `What are the key trends impacting the performance of the Indian healthcare sector?`\"}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"Suzlon won a 381 MW order from Zelestra India, furthering its renewable energy collaboration.\"}, {\"heading\": \"Market News Update\", \"content\": \"NTPCGREEN submitted a Monitoring Agency Report on IPO fund utilization for the June 2025 quarter.\"}, {\"heading\": \"Market News Update\", \"content\": \"MPHASIS partners with Flagstar Bank to enhance technology and support critical infrastructure growth.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the sector overview for the sector : Healthcare\"}<><>{\"type\": \"text\", \"values\": \"Sector Overview: Healthcare\\nMarket Cap: 28.46 lakh Cr | Market Cap Share: 6.98% | Sector ROE: 14.75%

The pharmaceutical sector presents a diverse investment landscape with 86 companies spanning large, mid, and small-cap segments, demonstrating robust yearly returns of 8.08% that outperform the Nifty by 6.85%, with top performers like Sun Pharma and Divis Laboratories leading market capitalization.\"}<><>{\"type\": \"table\", \"values\": {\"Market Cap\": [\"Large Cap\", \"Mid Cap\", \"Small Cap\"], \"Percentage\": [\"8.14 %\", \"36.05 %\", \"55.81 %\"], \"Companies\": [7, 31, 48]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Top companies by Market Cap\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Stock\": [\"SUNPHARMA\", \"DIVISLAB\", \"CIPLA\", \"TORNTPHARM\", \"MAXHEALTH\"], \"Market Cap (Cr)\": [\"390000.0\", \"170000.0\", \"120000.0\", \"120000.0\", \"120000.0\"], \"Weekly Return\": [\"-7.14%\", \"-7.51%\", \"-5.08%\", \"-4.11%\", \"0.57%\"], \"Revenue (Cr)\": [\"50125.09\", \"8184.0\", \"26520.66\", \"10789.81\", \"5595.07\"], \"PE\": [\"34.92\", \"74.07\", \"22.74\", \"63.65\", \"113.57\"], \"Score\": [\"7\", \"9\", \"10\", \"8\", \"5\"], \"ROE (%)\": [\"16.13\", \"12.15\", \"16.63\", \"25.38\", \"13.47\"]}}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Returns comparison\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Timeframe\": [\"Daily\", \"Weekly\", \"Monthly\", \"6 Months\", \"Yearly\"], \"Sector Return\": [\"0.07%\", \"-4.85%\", \"-2.39%\", \"3.30%\", \"8.08%\"], \"Nifty Return\": [\"0.09%\", \"-0.70%\", \"-3.40%\", \"4.40%\", \"1.23%\"], \"Analysis\": [\"Underperformed wrt nifty by 0.02%\", \"Underperformed wrt nifty by 4.15%\", \"Outperformed wrt nifty by 1.01%\", \"Underperformed wrt nifty by 1.10%\", \"Outperformed wrt nifty by 6.85%\"]}}]}}<><>{\"type\": \"thinking_step\", \"values\": \"Exploring comprehensive performance insights across the Indian healthcare sector to uncover underlying performance patterns.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Investigating recent news and sector-specific developments to understand current market dynamics and driving forces.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Conducting an in-depth examination of sector-wide trends, including regulatory shifts, policy implications, technological integration, and market transformations.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Identifying critical growth catalysts, potential obstacles, and emerging opportunities within the Indian healthcare landscape.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Synthesizing research findings to articulate the most significant trends influencing overall sector performance.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Curating the research into a final output to answer the user query\"}<><>{\"type\": \"thinking_step\", \"values\": \"Curating the research into a final output to answer the user query\"}<>The Indian healthcare sector, as of August 7, 2025, is witnessing dynamic shifts driven by regulatory reforms, digital transformation, and robust financial performance. Here\u2019s a concise sector-level analysis highlighting the key trends and their market implications:\n\n**Key Financial & Market Trends**\n\n| Company | Market Cap (\u20b9 Cr) | 2024 Revenue (\u20b9 Cr) | 2024 Net Profit (\u20b9 Cr) | 2024 Profit Margin (%) | 1M Return (%) | PE Ratio |\n|-----------------|------------------|---------------------|------------------------|-----------------------|--------------|----------|\n| **Sun Pharma** | **3,90,000** | **50,125** | **9,576** | **19.90** | - | - |\n| **Divi\u2019s Lab** | **1,70,000** | **8,184** | **1,600** | **20.28** | - | - |\n| **Cipla** | **1,20,000** | **26,521** | **4,121** | **11.73** | - | - |\n| **Max Healthcare** | **1,20,000** | **5,595** | **1,057** | **19.56** | - | - |\n| **Torrent Pharma** | **1,20,000** | **10,789** | **1,656** | **9.92** | - | - |\n\n- **Top 5 by 1-Month Return:** Vimta Labs (**40.28%**), Thyrocare (**21.73%**), Acutaas Chemicals (**13.97%**), Glenmark (**12.73%**), Senores Pharma (**12.67%**).\n\n**Sector-Wide Performance & Valuation**\n- Average PE ratio: **38.98**; average PB ratio: **6.73**.\n- Recent returns show volatility: mean daily return **-0.22%**, mean monthly return **-1.54%**.\n- Mutual funds hold significant stakes in leaders like Sun Pharma (over **1.86%** of shares), Divi\u2019s Lab (**2.24%**), and Apollo Hospitals (**1.36%**).\n\n**Major Sectoral Drivers**\n- **Regulatory reforms:** UCPMP 2024 and tighter oversight on health claims are increasing compliance costs but boosting transparency.\n- **Export headwinds:** Potential US tariffs and dependence on Chinese raw materials are prompting companies to diversify and seek government support.\n- **Digital & AI adoption:** Rapid digitization (over **500 million** health records) and AI integration are improving efficiency and patient care.\n- **Sustainability focus:** Green manufacturing and waste management are gaining traction, with long-term cost and brand benefits.\n- **Investment surge:** Private equity inflows hit **$5.5 billion** in 2023, fueling infrastructure and technology upgrades.\n\n**Market Sentiment & Outlook**\n- The sector is attracting strong institutional interest, with mutual funds and FIIs increasing allocations.\n- Policy support, digital health, and export resilience are expected to drive medium-term growth, though regulatory and global trade risks remain.\n\nWould you like a deeper dive into digital health trends, regulatory impacts, or a comparison of top-performing stocks in this sector?<>{\"type\": \"follow-up\", \"options\": [{\"label\": \"label_0\", \"value\": \"Are there any recent regulatory changes or policy updates affecting the Indian healthcare sector?\"}, {\"label\": \"label_1\", \"value\": \"How have SUNPHARMA, DIVISLAB, and CIPLA performed relative to their historical averages over the past month?\"}, {\"label\": \"label_2\", \"value\": \"What are the upcoming catalysts or events that could influence the healthcare stocks in India?\"}, {\"label\": \"label_3\", \"value\": \"Can we analyze the institutional investor activity or foreign fund flows in these healthcare companies?\"}]}<>", "follow_up": ["Are there any recent regulatory changes or policy updates affecting the Indian healthcare sector?", "How have SUNPHARMA, DIVISLAB, and CIPLA performed relative to their historical averages over the past month?", "What are the upcoming catalysts or events that could influence the healthcare stocks in India?", "Can we analyze the institutional investor activity or foreign fund flows in these healthcare companies?"]}, "query_2.02": {"query": "What opportunities does the Indian healthcare sector see in the global weight-loss drug market?", "response": "<>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `What opportunities does the Indian healthcare sector see in the global weight-loss drug market?`\"}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"NEULANDLAB announced its financial results for the quarter ended June 30, 2025.\"}, {\"heading\": \"Market News Update\", \"content\": \"Suzlon won a 381 MW order from Zelestra India, furthering its renewable energy collaboration.\"}, {\"heading\": \"Market News Update\", \"content\": \"NCC has submitted its Responsibility and Sustainability Report for FY 2024-25 to BSE.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the sector overview for the sector : Healthcare\"}<><>{\"type\": \"text\", \"values\": \"Sector Overview: Healthcare\\nMarket Cap: 28.46 lakh Cr | Market Cap Share: 6.98% | Sector ROE: 14.75%

The pharmaceutical sector presents a diverse investment landscape with 86 companies spanning large, mid, and small-cap segments, demonstrating robust yearly returns of 8.08% that outperform the Nifty by 6.85%, with top performers like Sun Pharma and Divis Laboratories leading market capitalization.\"}<><>{\"type\": \"table\", \"values\": {\"Market Cap\": [\"Large Cap\", \"Mid Cap\", \"Small Cap\"], \"Percentage\": [\"8.14 %\", \"36.05 %\", \"55.81 %\"], \"Companies\": [7, 31, 48]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Top companies by Market Cap\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Stock\": [\"SUNPHARMA\", \"DIVISLAB\", \"CIPLA\", \"TORNTPHARM\", \"MAXHEALTH\"], \"Market Cap (Cr)\": [\"390000.0\", \"170000.0\", \"120000.0\", \"120000.0\", \"120000.0\"], \"Weekly Return\": [\"-7.14%\", \"-7.51%\", \"-5.08%\", \"-4.11%\", \"0.57%\"], \"Revenue (Cr)\": [\"50125.09\", \"8184.0\", \"26520.66\", \"10789.81\", \"5595.07\"], \"PE\": [\"34.92\", \"74.07\", \"22.74\", \"63.65\", \"113.57\"], \"Score\": [\"7\", \"9\", \"10\", \"8\", \"5\"], \"ROE (%)\": [\"16.13\", \"12.15\", \"16.63\", \"25.38\", \"13.47\"]}}]}}<><>{\"type\": \"accordion\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Returns comparison\"}, \"answer\": [{\"type\": \"table\", \"values\": {\"Timeframe\": [\"Daily\", \"Weekly\", \"Monthly\", \"6 Months\", \"Yearly\"], \"Sector Return\": [\"0.07%\", \"-4.85%\", \"-2.39%\", \"3.30%\", \"8.08%\"], \"Nifty Return\": [\"0.09%\", \"-0.70%\", \"-3.40%\", \"4.40%\", \"1.23%\"], \"Analysis\": [\"Underperformed wrt nifty by 0.02%\", \"Underperformed wrt nifty by 4.15%\", \"Outperformed wrt nifty by 1.01%\", \"Underperformed wrt nifty by 1.10%\", \"Outperformed wrt nifty by 6.85%\"]}}]}}<><>{\"type\": \"thinking_step\", \"values\": \"Exploring the current performance landscape and identifying key players within the Indian healthcare sector.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Collecting and synthesizing recent developments in weight-loss drug research, pharmaceutical innovations, and emerging healthcare sector opportunities.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Investigating specific pharmaceutical capabilities and potential global market engagement strategies for weight-loss drug development.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Integrating research findings to pinpoint strategic opportunities for healthcare companies in the expanding weight-loss drug market.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Curating the research into a final output to answer the user query\"}<><>{\"type\": \"thinking_step\", \"values\": \"Curating the research into a final output to answer the user query\"}<>The Indian healthcare sector, especially pharmaceutical companies, is witnessing strong momentum as they target the rapidly expanding global weight-loss drug market. This sector is strategically positioned to benefit from the global anti-obesity drugs market, which was valued at **$12.8 billion in 2024** and is projected to reach **$104.9 billion by 2035** (CAGR: **21.1%**).\n\n### Key Developments & Opportunities\n\n| Company | Market Cap (\u20b9 Cr) | Recent News/Initiatives | R&D/Drug Focus | 2024 Revenue (\u20b9 Cr) | ROE (%) | 1Y Return (%) |\n|--------------|------------------|------------------------|----------------|---------------------|---------|---------------|\n| Sun Pharma | 3,90,000 | Developing Utreglutide (GLP-1 agonist) for global launch in 5 years | Proprietary GLP-1 | 50,125 | 16.13 | -8.47 |\n| Biocon | 51,130 | Plans generic Wegovy launch in India/Canada by 2027 | Semaglutide generics | 15,723 | 7.00 | 1.38 |\n| Dr. Reddy\u2019s | - | Launching generic Wegovy in 87 markets from 2026 | Semaglutide generics | - | - | - |\n| Cipla | - | Preparing for GLP-1 drugs, exploring partnerships | GLP-1 generics | - | - | - |\n| Mankind | 1,10,000 | Targeting GLP-1 segment post-patent expiry | GLP-1 generics | 10,541 | 23.14 | 27.13 |\n\n- **Sales of anti-obesity drugs in India have surged**: Wegovy and Mounjaro sales doubled in July 2025, with Mounjaro reaching **\u20b9470 crore** in monthly sales.\n- **Patent expiries** for key drugs like semaglutide (Ozempic, Wegovy) are opening the market for Indian generics.\n- **R&D investments**: Sun Pharma and Biocon are advancing clinical trials for proprietary and generic GLP-1 drugs.\n- **Strategic partnerships**: Cipla and others are exploring collaborations with global majors for technology transfer and co-marketing.\n\n### Financial & Market Impact\n\n- Companies with high R&D and global ambitions (Sun Pharma, Biocon, Mankind) are likely to see **improved revenue growth and investor interest**.\n- **Export potential** is significant, as Indian firms can supply cost-effective generics and APIs to global markets.\n- **Stock performance**: Mankind Pharma (+27% 1Y), Suven Pharma (+58%), and others with strong R&D and positive returns are well-placed for further upside.\n\n### Sector Trends\n\n- The Indian pharma sector\u2019s **API manufacturing strength** and cost advantage position it as a key global supplier.\n- Regulatory changes in the US (Medicare/Medicaid coverage for weight-loss drugs from 2026/27) will further boost demand.\n\nWould you like a deeper dive into the R&D pipelines or financials of any specific company, or an explanation of how GLP-1 drugs work and their market impact?<>{\"type\": \"follow-up\", \"options\": [{\"label\": \"label_0\", \"value\": \"Are there any Indian pharmaceutical companies actively developing weight-loss drugs or related treatments?\"}, {\"label\": \"label_1\", \"value\": \"How are major healthcare companies in India positioned to capitalize on global trends in weight management and obesity treatments?\"}, {\"label\": \"label_2\", \"value\": \"What regulatory or policy developments in India could impact the growth of the healthcare sector in this niche?\"}, {\"label\": \"label_3\", \"value\": \"Can you provide insights into the investment opportunities or risks associated with Indian healthcare firms focusing on weight-loss solutions?\"}]}<>", "follow_up": ["Are there any Indian pharmaceutical companies actively developing weight-loss drugs or related treatments?", "How are major healthcare companies in India positioned to capitalize on global trends in weight management and obesity treatments?", "What regulatory or policy developments in India could impact the growth of the healthcare sector in this niche?", "Can you provide insights into the investment opportunities or risks associated with Indian healthcare firms focusing on weight-loss solutions?"]}, "query_2.03": {"query": "How has these stocks been moving in the last 5 days?", "response": "<>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `How have Sun Pharma, Divis Laboratories, Lupin, and GPT Healthcare stocks been moving in the last 5 days?`\"}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Sun Pharmaceutical Industries\", \"content\": \"Sun Pharmaceutical Industries received SEBI disclosure regarding substantial share acquisition on August 2, 2025.\"}, {\"heading\": \"Market News Update\", \"content\": \"WAAREEENER is up 1.48% at Rs. 3037.00 with 52-week highs of Rs. 3740.75.\"}, {\"heading\": \"Market News Update\", \"content\": \"POWERGRID to present at Investors\\u2019 & Analysts\\u2019 meet on August 1, 2025, in Mumbai.\"}, {\"heading\": \"Divi's Laboratories\", \"content\": \"DIVISLAB announced its unaudited financial results for the quarter ended June 30, 2025.\"}, {\"heading\": \"Lupin\", \"content\": \"LUPIN's stock is down 1.12% to Rs. 1842.40 amid significant profit growth.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `How have the stocks in the Indian healthcare sector, such as Sun Pharma, Divi's Labs, Max Healthcare, Cipla, Torrent Pharma, Lupin, Biocon, Dr. Reddy\\u2019s, and Glaxo, been moving in the last 5 days?`\"}<><>{\"type\": \"thinking_step\", \"values\": \"Analyzing the stock price movements of four pharmaceutical companies over the past five trading days.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Collecting comprehensive stock details and performance metrics for the specified pharmaceutical stocks.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Extracting detailed price and trading information for each stock, focusing on open, high, low, close, and volume data.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Computing daily price fluctuations, percentage changes, and identifying volume trend patterns.\"}<><>{\"type\": \"thinking_step\", \"values\": \"Conducting a comparative analysis of stock performances to uncover relative market positioning and recent movement characteristics.\"}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"GODREJPROP trades at Rs 2109.35, up 0.31%, following recent land acquisition in Vadodara.\"}, {\"heading\": \"Market News Update\", \"content\": \"JUBLINGREA has uploaded the audio recording of its Q1 FY26 investors' conference call online.\"}, {\"heading\": \"Market News Update\", \"content\": \"GESHIP reports 41.87% fall in Q1 net profit to Rs 388.45 crore for FY26.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the sector overview for the sector : Healthcare\"}<><>{\"type\": \"text\", \"values\": \"Sector Overview: Healthcare\\nMarket Cap: 28.46 lakh Cr | Market Cap Share: 6.98% | Sector ROE: 14.75%

Stock	Latest Close (\u20b9)	5-Day Trend	Change % (Last Day)	Total Volume (5 Days)
Sun Pharma	1,590.60	Down from 1,629.70 (Aug 1) to 1,590.60 (Aug 7)	-0.29%	1.78 crore
Divis Laboratories	6,124.00	Down from 6,361.50 (Aug 1) to 6,124.00 (Aug 7)	-0.15%	30.78 lakh
Lupin	1,941.90	Up from 1,867.30 (Aug 1) to 1,941.90 (Aug 7)	+4.87%	92.87 lakh
GPT Healthcare	162.83	Down from 179.37 (Aug 1) to 162.83 (Aug 7)	-8.74%	44.45 lakh

\n\n**Key insights:**\n- **Lupin** outperformed peers with a strong upward move, closing nearly \u20b975 higher over the week, supported by robust volumes.\n- **Sun Pharma** and **Divis Laboratories** saw mild declines, indicating some profit booking after previous rallies.\n- **GPT Healthcare** experienced a sharp correction, dropping over 8% on the last day, possibly due to sector rotation or company-specific news.\n- Volumes remained healthy across all counters, with Sun Pharma leading in traded quantity.\n\nThis week\u2019s movement highlights mixed sentiment in pharma, with select stocks like Lupin attracting buying interest. Would you like a deeper dive into the news, results, or management commentary driving these moves, or a sector-wide comparison?<>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Analyst recommendation and Stock score for SUNPHARMA 1\"}, \"answer\": [{\"type\": \"analyst_ranking\", \"values\": [{\"title\": \"Strong Buy\", \"pct\": 36.11, \"color\": \"#19A574\"}, {\"title\": \"Buy\", \"pct\": 44.44, \"color\": \"#4EE2AE\"}, {\"title\": \"Hold\", \"pct\": 11.11, \"color\": \"#D3D3D3\"}, {\"title\": \"Sell\", \"pct\": 5.56, \"color\": \"#EA6776\"}, {\"title\": \"Strong Sell\", \"pct\": 2.78, \"color\": \"#D8011B\"}]}, {\"type\": \"stock_score_report\", \"values\": {\"heading\": {\"title\": \"Stock Score\", \"image_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\"}, \"score_info\": {\"score\": 7, \"score_max\": 10, \"image_url\": \"https://storage.googleapis.com/insights_page_assets/scores/ice.png\", \"bg_color\": \"#FFE8B3\", \"fill_color\": \"#FFAA49\"}, \"outlook\": {\"text\": \"Neutral Outlook\", \"color\": \"#FFAB48\"}, \"indicator_bg_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\", \"indicators\": [{\"name\": \"Earnings\", \"score\": 3}, {\"name\": \"Fundamentals\", \"score\": 9}, {\"name\": \"Relative Valuation\", \"score\": 4}, {\"name\": \"Risk\", \"score\": 10}, {\"name\": \"Price Momentum\", \"score\": 7}], \"legend\": [{\"title\": \"NEGATIVE (1-4)\", \"color\": \"#FF8080\"}, {\"title\": \"NEUTRAL (5-7)\", \"color\": \"#F8F4A6\"}, {\"title\": \"POSITIVE (8-10)\", \"color\": \"#B3FFBE\"}], \"show_empty_ui\": false}}]}}<><>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Analyst recommendation and Stock score for DIVISLAB 2\"}, \"answer\": [{\"type\": \"analyst_ranking\", \"values\": [{\"title\": \"Strong Buy\", \"pct\": 12.5, \"color\": \"#19A574\"}, {\"title\": \"Buy\", \"pct\": 25, \"color\": \"#4EE2AE\"}, {\"title\": \"Hold\", \"pct\": 25, \"color\": \"#D3D3D3\"}, {\"title\": \"Sell\", \"pct\": 25, \"color\": \"#EA6776\"}, {\"title\": \"Strong Sell\", \"pct\": 12.5, \"color\": \"#D8011B\"}]}, {\"type\": \"stock_score_report\", \"values\": {\"heading\": {\"title\": \"Stock Score\", \"image_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\"}, \"score_info\": {\"score\": 9, \"score_max\": 10, \"image_url\": \"https://storage.googleapis.com/insights_page_assets/scores/fire.png\", \"bg_color\": \"#CBFFB7\", \"fill_color\": \"#58DE6B\"}, \"outlook\": {\"text\": \"Positive Outlook\", \"color\": \"#359501\"}, \"indicator_bg_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\", \"indicators\": [{\"name\": \"Earnings\", \"score\": 10}, {\"name\": \"Fundamentals\", \"score\": 6}, {\"name\": \"Relative Valuation\", \"score\": 1}, {\"name\": \"Risk\", \"score\": 10}, {\"name\": \"Price Momentum\", \"score\": 10}], \"legend\": [{\"title\": \"NEGATIVE (1-4)\", \"color\": \"#FF8080\"}, {\"title\": \"NEUTRAL (5-7)\", \"color\": \"#F8F4A6\"}, {\"title\": \"POSITIVE (8-10)\", \"color\": \"#B3FFBE\"}], \"show_empty_ui\": false}}]}}<><>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Analyst recommendation and Stock score for LUPIN 3\"}, \"answer\": [{\"type\": \"analyst_ranking\", \"values\": [{\"title\": \"Strong Buy\", \"pct\": 17.65, \"color\": \"#19A574\"}, {\"title\": \"Buy\", \"pct\": 35.29, \"color\": \"#4EE2AE\"}, {\"title\": \"Hold\", \"pct\": 38.24, \"color\": \"#D3D3D3\"}, {\"title\": \"Sell\", \"pct\": 8.82, \"color\": \"#EA6776\"}, {\"title\": \"Strong Sell\", \"pct\": 0, \"color\": \"#D8011B\"}]}, {\"type\": \"stock_score_report\", \"values\": {\"heading\": {\"title\": \"Stock Score\", \"image_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\"}, \"score_info\": {\"score\": 10, \"score_max\": 10, \"image_url\": \"https://storage.googleapis.com/insights_page_assets/scores/fire.png\", \"bg_color\": \"#CBFFB7\", \"fill_color\": \"#58DE6B\"}, \"outlook\": {\"text\": \"Positive Outlook\", \"color\": \"#359501\"}, \"indicator_bg_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\", \"indicators\": [{\"name\": \"Earnings\", \"score\": 9}, {\"name\": \"Fundamentals\", \"score\": 9}, {\"name\": \"Relative Valuation\", \"score\": 6}, {\"name\": \"Risk\", \"score\": 9}, {\"name\": \"Price Momentum\", \"score\": 7}], \"legend\": [{\"title\": \"NEGATIVE (1-4)\", \"color\": \"#FF8080\"}, {\"title\": \"NEUTRAL (5-7)\", \"color\": \"#F8F4A6\"}, {\"title\": \"POSITIVE (8-10)\", \"color\": \"#B3FFBE\"}], \"show_empty_ui\": false}}]}}<><>{\"type\": \"accordion_with_carousel\", \"values\": {\"header\": {\"type\": \"text\", \"values\": \"Analyst recommendation and Stock score for GPTHEALTH 4\"}, \"answer\": [{\"type\": \"analyst_ranking\", \"values\": [{\"title\": \"Strong Buy\", \"pct\": 0, \"color\": \"#19A574\"}, {\"title\": \"Buy\", \"pct\": 0, \"color\": \"#4EE2AE\"}, {\"title\": \"Hold\", \"pct\": 100, \"color\": \"#D3D3D3\"}, {\"title\": \"Sell\", \"pct\": 0, \"color\": \"#EA6776\"}, {\"title\": \"Strong Sell\", \"pct\": 0, \"color\": \"#D8011B\"}]}, {\"type\": \"stock_score_report\", \"values\": {\"heading\": {\"title\": \"Stock Score\", \"image_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\"}, \"score_info\": {\"score\": 6, \"score_max\": 10, \"image_url\": \"https://storage.googleapis.com/insights_page_assets/scores/ice.png\", \"bg_color\": \"#FFE8B3\", \"fill_color\": \"#FFAA49\"}, \"outlook\": {\"text\": \"Neutral Outlook\", \"color\": \"#FFAB48\"}, \"indicator_bg_url\": \"https://storage.googleapis.com/home_page_assets/headings/your_portfolios_white.png\", \"indicators\": [{\"name\": \"Earnings\", \"score\": 2}, {\"name\": \"Fundamentals\", \"score\": 10}, {\"name\": \"Relative Valuation\", \"score\": 6}, {\"name\": \"Risk\", \"score\": 10}, {\"name\": \"Price Momentum\", \"score\": 1}], \"legend\": [{\"title\": \"NEGATIVE (1-4)\", \"color\": \"#FF8080\"}, {\"title\": \"NEUTRAL (5-7)\", \"color\": \"#F8F4A6\"}, {\"title\": \"POSITIVE (8-10)\", \"color\": \"#B3FFBE\"}], \"show_empty_ui\": false}}]}}<><>{\"type\": \"follow-up\", \"options\": [{\"label\": \"label_0\", \"value\": \"Are there any recent news or events impacting these pharmaceutical stocks?\"}, {\"label\": \"label_1\", \"value\": \"What are the technical indicators suggesting for Sun Pharma and Lupin in the short term?\"}, {\"label\": \"label_2\", \"value\": \"How do these stocks compare to their 1-month performance and moving averages?\"}, {\"label\": \"label_3\", \"value\": \"Are institutional investors increasing their holdings in any of these pharmaceutical companies?\"}]}<>", "follow_up": ["Are there any recent news or events impacting these pharmaceutical stocks?", "What are the technical indicators suggesting for Sun Pharma and Lupin in the short term?", "How do these stocks compare to their 1-month performance and moving averages?", "Are institutional investors increasing their holdings in any of these pharmaceutical companies?"]}, "query_2.04": {"query": "What is the growth outlook for the Indian pharmaceutical sector?", "response": "<>{\"type\": \"thinking_step\", \"values\": \"Interpreting the user query as `What is the growth outlook for the Indian pharmaceutical sector?`\"}<><>{\"type\": \"news_feed\", \"values\": [{\"heading\": \"Market News Update\", \"content\": \"Schaeffler India expands its industrial bearings portfolio with new products made in India.\"}, {\"heading\": \"Market News Update\", \"content\": \"SAMMAANCAP approved the allotment of 17,36,110 NCDs, raising \\u20b9173.61 crore via public issue.\"}, {\"heading\": \"Market News Update\", \"content\": \"RADICO's stock rises 3.66% to Rs. 2831.70 after strong Q1 profit results.\"}]}<><>{\"type\": \"thinking_step\", \"values\": \"Preparing the sector overview for the sector : Healthcare\"}<><>{\"type\": \"text\", \"values\": \"Sector Overview: Healthcare\\nMarket Cap: 28.46 lakh Cr | Market Cap Share: 6.98% | Sector ROE: 14.75%

Metric	Value	Context
Market Cap	Data not available	Reflects company size; not provided here
P/E Ratio	8.51	Significantly below sector average (57.87), indicating undervaluation or higher earnings
P/B Ratio	2.04	Lower than sector (6.33), suggesting attractive valuation
EPS	\u20b975.62	Strong earnings per share
Dividend Yield	0.89%	Modest yield, typical for growth-focused auto companies
ROE	49.9%	Exceptional return on equity, showing efficient capital use
ROA	9.43%	Healthy asset efficiency
ROCE	20.33%	Strong returns on capital employed
Total Revenue (2024)	\u20b94,39,708 crore	Indicates robust sales scale
Net Profit (2024)	\u20b931,399 crore	Reflects strong profitability
Profit Margin (2024)	7.48%	Solid margin for the auto sector
Promoters Holding	42.57%	Shows strong promoter confidence
FII Holding	17.17%	Indicates healthy foreign investor interest
DII Holding	17.25%	Reflects domestic institutional support
Public Holding	23.01%	Represents retail participation

Company	Market Cap (\u20b9 Cr)	ROE 2022	ROE 2023	ROE 2024	ROCE 2022	ROCE 2023	ROCE 2024
Ashok Leyland	70,680	-3.79%	17.23%	30.88%	5.30%	12.33%	15.92%
Bajaj Auto	2,20,000	21.60%	20.50%	26.51%	26.70%	26.51%	33.47%
Eicher Motors	1,50,000	14.02%	21.19%	24.32%	18.31%	27.48%	31.35%
Hero MotoCorp	86,240	14.92%	17.26%	21.84%	19.47%	23.93%	29.50%
M&M	3,80,000	16.44%	22.09%	20.11%	11.92%	15.02%	14.88%
Maruti Suzuki	3,90,000	7.20%	12.72%	16.84%	8.87%	16.26%	21.82%
Tata Motors	2,40,000	-22.53%	5.99%	49.90%	1.23%	7.67%	20.33%
TVS Motor	1,40,000	17.77%	26.44%	28.54%	11.32%	14.11%	15.49%

Stock	Sector	Market Cap (\u20b9 Crores)	1D Return (%)	1W Return (%)	1M Return (%)	ROE (2024, %)	P/E	P/B
Hero MotoCorp	Automobile Ancillaries	8,62,400	4.02	9.25	7.43	21.84	21.23	4.83
Lupin	Healthcare	8,52,900	4.74	0.54	1.32	14.61	27.02	5.18
Indian Bank	Bank	8,36,700	0.73	3.29	0.52	16.65	7.72	1.35

Stock Symbol	Company Name	Market Cap (\u20b9 Crore)
TCS	Tata Consultancy Services	10,90,000
INFY	Infosys	6,10,000
HCLTECH	HCL Technologies	3,90,000
WIPRO	Wipro	2,50,000
LTIM	LTIMindtree	1,50,000

Company	P/E Ratio	Sector P/E	ROE (2024)	EPS (2024)	Market Cap (\u20b9 Cr)	1Y Return (%)	Revenue/Profit Trend
Dhani Services	-10.34	33.95	-10.33%	-6.17	3,420	20.17	Consistent losses, negative growth
Sundaram Finance	35.51	33.94	13.55%	130.31	50,340	9.60	Steady growth, strong profitability
Prudent Corp	57.17	33.94	33.38%	33.51	11,050	21.35	High growth, robust ROE

Mutual Fund	Key Finance Holdings	Finance Sector Allocation	1Y Return	Latest AUM (\u20b9 crore)	Recent News/Updates
HDFC Financial Services Fund	Bajaj Finserv, Jio Financial, IRFC, PFC	85%	32.4%	4,200	Launched in 2024, strong inflows seen in July 2025
ICICI Prudential Financial Services Fund	Bajaj Finserv, HDFC AMC, REC, PFC	78%	29.8%	3,600	Consistent outperformance vs. category average
Nippon India Banking & Financial Services Fund	Bajaj Finserv, Shriram Finance, Cholamandalam, Muthoot Finance	80%	28.5%	5,100	High FII inflows in August 2025